Cargando…
BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?
Coronavirus disease 2019 (COVID-19) is a severe acute respiratory syndrome caused by Coronavirus 2 (SARS-CoV-2). In the light of its rapid global spreading, on 11 March 2020, the World Health Organization has declared it a pandemic. Interestingly, the global spreading of the disease is not uniform,...
Autores principales: | Sharma, Abhibhav, Kumar Sharma, Saurabh, Shi, Yufang, Bucci, Enrico, Carafoli, Ernesto, Melino, Gerry, Bhattacherjee, Arnab, Das, Gobardhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341995/ https://www.ncbi.nlm.nih.gov/pubmed/32641762 http://dx.doi.org/10.1038/s41419-020-2720-9 |
Ejemplares similares
-
Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
por: Carafoli, Ernesto
Publicado: (2021) -
Is hydroxychloroquine beneficial for COVID-19 patients?
por: Li, Xing, et al.
Publicado: (2020) -
Delayed Onset Chloroquine Retinopathy Presenting 10 Years after Long-Term Usage of Chloroquine
por: Kazi, Mohmmad Salman, et al.
Publicado: (2013) -
Luteolin-mediated Kv1.3 K(+) channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice
por: Singh, Dhiraj Kumar, et al.
Publicado: (2020) -
Correction: Luteolin-mediated Kv1.3 K(+) channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice
por: Singh, Dhiraj Kumar, et al.
Publicado: (2021)